Entity Public Float of ARROWHEAD PHARMACEUTICALS, INC. from 31 Mar 2011 to 31 Mar 2025

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly Entity Public Float in USD history and change rate from 31 Mar 2011 to 31 Mar 2025.
  • ARROWHEAD PHARMACEUTICALS, INC. Entity Public Float for the quarter ending 31 Mar 2025 was $1,400,000,000, a 53% decline year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,400,000,000 -$1,600,000,000 -53% 31 Mar 2025 10-K 25 Nov 2025 2025 FY
Q1 2024 $3,000,000,000 +$700,000,000 +30% 31 Mar 2024 10-K/A 10 Oct 2025 2024 FY
Q1 2023 $2,300,000,000 -$1,800,000,000 -44% 31 Mar 2023 10-K 29 Nov 2023 2023 FY
Q1 2022 $4,100,000,000 -$1,800,000,000 -31% 31 Mar 2022 10-K 28 Nov 2022 2022 FY
Q1 2021 $5,900,000,000 +$3,000,000,000 +103% 31 Mar 2021 10-K 22 Nov 2021 2021 FY
Q1 2020 $2,900,000,000 +$1,200,000,000 +71% 31 Mar 2020 10-K 23 Nov 2020 2020 FY
Q1 2019 $1,700,000,000 +$1,081,000,000 +175% 31 Mar 2019 10-K 25 Nov 2019 2019 FY
Q1 2018 $619,000,000 +$482,000,000 +352% 31 Mar 2018 10-K 11 Dec 2018 2018 FY
Q1 2017 $137,000,000 -$153,000,000 -53% 31 Mar 2017 10-K 12 Dec 2017 2017 FY
Q1 2016 $290,000,000 -$117,000,000 -29% 31 Mar 2016 10-K 14 Dec 2016 2016 FY
Q1 2015 $407,000,000 -$353,000,000 -46% 31 Mar 2015 10-K 14 Dec 2015 2015 FY
Q1 2014 $760,000,000 +$722,000,000 +1900% 31 Mar 2014 10-K 25 Nov 2014 2014 FY
Q1 2013 $38,000,000 -$30,000,000 -44% 31 Mar 2013 10-K 18 Dec 2013 2013 FY
Q1 2012 $68,000,000 +$15,000,000 +28% 31 Mar 2012 10-K 28 Dec 2012 2012 FY
Q1 2011 $53,000,000 31 Mar 2011 10-K 20 Dec 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.